Top 5 Pharmacy Times Pediatrics Articles of 2023

1. FDA Approves Vaccine for Pregnant Individuals to Prevent Respiratory Syncytial Virus in Infants

It is the first vaccine of its kind to be FDA approved, and it met multiple safety and efficacy standards through clinical trials. Read More Here.

2. Researchers Create Growth Chart from AI-Based Tool to Measure Muscle Mass

The growth chart could be a fast and accessible resource to indicate lean muscle mass in children. Read More Here.

3. Cognitive Training Programs Have No Long-Term Benefit for Children Born Very Preterm

Children born at 24- through 34-weeks’ gestation could have neurobehavioral problems and developmental dysfunctions, including language, executive function, attention, and behavioral disorders. Read More Here.

4. Common Cold Virus Associated With Rare Blood Clotting Disorder

Prior to this study, anti-platelet factor 4 disorder was thought to be caused by exposure to heparin or autoimmune conditions. Read More Here.

5. FDA Approves Elfornithine for the Treatment of High-Risk Neuroblastoma in Adult, Pediatric Patients

This is the first FDA approval for a therapy intended to reduce the risk of relapse in patients with high-risk neuroblastoma. Read More Here.